logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 10898534 B1

PDFFull Text
Date of Patent:
Jan. 26, 2021

Filed:

Aug. 05, 2019

Compositions and methods useful in treatment of lower urinary tract symptoms, benign prostatic hyperplasia, erectile dysfunction and other diseases or symptoms

Applicant:

Naturex Inc., South Hackensack, NJ (US);

Inventors:

Emilie Annie Claudie Fromentin, Brain sur L'authion, FR;

Douglas Andrew Klaiber, Forestdale, MA (US);

Daniel David Souza, East Sandwich, MA (US);

Assignee:

NATUREX Inc., South Hackensack, NJ (US);

Attorneys:

Curatolo Sidoti Co., LPA

Salvatore A. Sidoti

Primary Examiner:

Michael Barker

Assistant Examiner:

Deborah A Davis

Int. Cl.
CPC ...
A61K 36/45 (2006.01); A61K 9/48 (2006.01); A61K 9/00 (2006.01); A61K 9/16 (2006.01); A61K 9/20 (2006.01); A61K 31/09 (2006.01); A61K 31/192 (2006.01); A61K 31/216 (2006.01); A61K 31/34 (2006.01); A61K 31/341 (2006.01); A61K 31/352 (2006.01); A61K 31/353 (2006.01); A61K 31/7048 (2006.01);
U.S. Cl.
CPC ...
A61K 36/45 (2013.01); A61K 9/0053 (2013.01); A61K 9/16 (2013.01); A61K 9/20 (2013.01); A61K 9/48 (2013.01); A61K 9/4875 (2013.01); A61K 31/09 (2013.01); A61K 31/192 (2013.01); A61K 31/216 (2013.01); A61K 31/34 (2013.01); A61K 31/341 (2013.01); A61K 31/352 (2013.01); A61K 31/353 (2013.01); A61K 31/7048 (2013.01);
Abstract

The invention relates to therapeutic compositions, solid oral dosage forms, and methods for treating, preventing, or alleviating lower urinary tract symptoms (LUTS), benign prostatic hyperplasia (BPH), erectile dysfunction (ED), urinary incontinence, bladder obstruction, overactive bladder (OAB), underactive bladder, interstitial cystitis, prostatitis, bladder and prostate inflammation, prostate fibrosis or pelvic pain. The therapeutic compositions can comprise cranberry powder enriched in cranberry seeds or cranberry seed meal.

Find Patent Forward Citations

Loading…